Absorption |
Blood-Brain Barrier | BBB+ | 0.9384 |
Human Intestinal Absorption | HIA+ | 0.8859 |
Caco-2 Permeability | Caco2- | 0.5231 |
P-glycoprotein Substrate | Non-substrate | 0.8815 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9756 |
Non-inhibitor | 0.9941 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9367 |
Distribution |
Subcellular localization | Mitochondria | 0.4999 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8582 |
CYP450 2D6 Substrate | Non-substrate | 0.8857 |
CYP450 3A4 Substrate | Non-substrate | 0.7957 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8470 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8644 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9085 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8929 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9219 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9345 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9156 |
Non-inhibitor | 0.9675 |
AMES Toxicity | AMES toxic | 0.8837 |
Carcinogens | Carcinogens | 0.7711 |
Fish Toxicity | Low FHMT | 0.9387 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.7487 |
Honey Bee Toxicity | High HBT | 0.7089 |
Biodegradation | Not ready biodegradable | 0.6341 |
Acute Oral Toxicity | II | 0.7103 |
Carcinogenicity (Three-class) | Non-required | 0.6243 |